Literature DB >> 26519618

Validated UPLC-MS/MS method for simultaneous determination of simvastatin, simvastatin hydroxy acid and berberine in rat plasma: Application to the drug-drug pharmacokinetic interaction study of simvastatin combined with berberine after oral administration in rats.

Mei Liu1, Xianying Su2, Guofei Li1, Guilian Zhao1, Limei Zhao3.   

Abstract

A rapid and sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) assay method was developed and validated for simultaneous quantification of simvastatin (SV), its metabolite simvastatin hydroxy acid (SVA) and berberine (BBR) in rat plasma. Separation was performed on Poroshell 120 EC-C18 column (4.6×50mm, 2.7μm) using gradient elution by mobile phase containing acetonitrile and 10mM ammonium acetate (pH 4.5). Polarity switch (positive-negative-positive ionization mode) was performed in a total run time of 4.0min. The lower limits of quantification (LLOQ) for SV, SVA and BBR were 0.10, 0.20 and 0.10ng/mL, respectively. The response function was established for concentration range of 0.10-100ng/mL for SV and BBR and 0.20-3000ng/mL for SVA, with a coefficient of correlation of >0.99 for all the compounds. The proposed method was applied to the drug-drug pharmacokinetic interaction study of SV combined with BBR after oral administration in rats.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Berberine; Determination; Drug–drug interaction; LC–MS–MS; Pharmacokinetics; Simvastatin

Mesh:

Substances:

Year:  2015        PMID: 26519618     DOI: 10.1016/j.jchromb.2015.09.033

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  7 in total

1.  Effects of ketoconazole on cyclophosphamide metabolism: evaluation of CYP3A4 inhibition effect using the in vitro and in vivo models.

Authors:  Le Yang; Chenyang Yan; Feng Zhang; Bo Jiang; Shouhong Gao; Youtian Liang; Lifeng Huang; Wansheng Chen
Journal:  Exp Anim       Date:  2017-11-13

2.  Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.

Authors:  Beth Buchanan; Qingfang Meng; Mathieu-Marc Poulin; Jonathan Zuccolo; Chike Godwin Azike; Joseph Gabriele; David Charles Baranowski
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

3.  Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats.

Authors:  Yuzhen Jia; Binger Xu; Jisen Xu
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 4.  Effects of Berberine on Atherosclerosis.

Authors:  Rui Rui; Haolan Yang; Yanke Liu; Yue Zhou; Xudong Xu; Chaohong Li; Shuying Liu
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

5.  Toxicity and toxicokinetics of the ethanol extract of Zuojin formula.

Authors:  Shuo Wang; Tao Zhang; Xiaoyan Liu; Zheng Yang; Ludi Li; Danping Shan; Yadong Gao; Yingzi Li; Yanying Li; Youbo Zhang; Qi Wang
Journal:  BMC Complement Med Ther       Date:  2022-08-15

6.  In Vivo and in Vitro Study on Drug-Drug Interaction of Lovastatin and Berberine from Pharmacokinetic and HepG2 Cell Metabolism Studies.

Authors:  Hanming Cui; Jialong Wang; Qiuyan Zhang; Mengmeng Dang; Hui Liu; Yu Dong; Lu Zhang; Fang Yang; Jianhua Wu; Xiaolin Tong
Journal:  Molecules       Date:  2016-04-08       Impact factor: 4.411

Review 7.  Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders.

Authors:  Maria A Neag; Andrei Mocan; Javier Echeverría; Raluca M Pop; Corina I Bocsan; Gianina Crişan; Anca D Buzoianu
Journal:  Front Pharmacol       Date:  2018-08-21       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.